跳至主要内容
临床试验/NCT00672672
NCT00672672撤回不适用

Autologous Platelet Gel in Wound Healing of Coronary Artery Bypass Grafting (CABG) Patients

University of Nebraska0 个研究点开始时间: 2009年1月13日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
主要终点
Healing and infection of surgical sites

研究概览

简要总结

This study will determine if autologous platelet gel (APG) on sternal incision and conduit sites will improve wound healing and decrease infection in coronary artery bypass grafting surgery patients.

详细描述

The purpose of this study is to determine if the use of autologous platelet gel (APG) on sternal incision and conduit sites will improve wound healing and decrease the incidence of infection in patients undergoing coronary artery bypass grafting surgery

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
19 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Any patient who meets criteria and consents to undergo a CABG procedure involving conduit sites and consents to this study.

排除标准

  • •Any patient, after inclusion, whom is later determined to have had on-going therapy that could influence wound healing such as radiation or chemotherapy, extensive steroid use, or accidental trauma such as burns, etc.

研究组 & 干预措施

Platelet Gel

Experimental

Participants receive platlet gel.

干预措施: autologous platelet gel (Biological)

Control (No platelet gel)

Placebo Comparator

Participants do not receive platlet gel.

干预措施: autologous platelet gel (Biological)

结局指标

主要结局

Healing and infection of surgical sites

时间窗: 30 days

The surgical sites will be assessed for degree of healing and signs and symptoms of infection on post-op days one and three and during the patients' follow up visits in the clinic.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验